ConsultantLive Members: Login | Register
ConsultantLive SearchMedica Medline Drugs

Powered by SearchMedica

 
About Us
Blogs
Dermclinic
Photoclinic
Pediatric Center
Multimedia
Topics
What's Your Diagnosis?
 

Home » Gout

Consultant. No. 2
 

What Next When Gout Remains Afoot?

February 1, 2006

Six months ago, I prescribed allopurinol(Drug information on allopurinol) for a patient with a history of podagra, several tophi in one toe, and an elevated uric acid level. The level has dropped to the low end of the normal range, and his urinary uric acid excretion is quite low. Yet despite treatment, he has had 2 more episodes of gout. Do you have any suggestions?

— MD

The first step is to confirm that your patient's "tophus" is not a subcutaneous nodule such as those associated with rheumatoid arthritis. This can be done by aspirating the nodule; the presence of monosodium urate crystals in the aspirate confirms tophaceous gout.

Optimal treatment requires a long-standing reduction in serum urate levels. It has been proposed that maintaining a serum urate level of less than 6 mg/dL—rather than a level in the normal range—will help ensure resolution of tophi and eventual cessation of acute gouty attacks.

Increase your patient's allopurinol dosage sufficiently to lower the serum urate level to less than 6 mg/dL and then measure the tophi to confirm that their size has decreased. The maximum effect from lowering serum urate levels occurs within 14 days. Thus, check levels 3 to 6 weeks after changing the allopurinol dosage. Continue to increase the dosage until the serum urate level falls below 6 mg/dL.

A potential problem with this approach is that a major change in the serum urate level induced by initiating a urate-lowering drug (such as allopurinol) or changing the dosage may precipitate a gouty attack or prolong an attack already in progress. Colchicine(Drug information on colchicine) is commonly used as prophylaxis against gouty attacks. Colchicine, 0.5 to 0.6 mg bid until the serum urate level drops below 6 mg/dL, significantly reduces the frequency of attacks of acute gout in patients whose hyperuricemia is controlled by allopurinol.

— Naomi Schlesinger, MD
   Associate Professor of Medicine
   Director, Clinical Rheumatology
   University of Medicine and Dentistry of New Jersey/
     Robert Wood Johnson Medical School
   New Brunswick

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Asthma

Atrial Fibrillation

Cardiovascular

Cerebrovascular

Developmental/Genetic

Diabetes

Diabetes Type 2

Fibromyalgia

Geriatrics

GI Disorders

Gout

Health Care Reform

HIV/AIDS

Hypertension

Infection

Mental Health

 

Musculoskeletal

Nervous System

Nutritional/Metabolic 

Otorhinolaryngologic 

Pain

Pediatrics

Physical Abuse

Respiratory Tract 

Rheumatic Diseases

Seasonal Allergies

Skin Diseases

Sleep Disorders

Urologic Diseases

Vaccines

Women’s Health

All Topics

 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Painful Red Ear
  • Facial Skin Problems—A Photo Essay
  • Go For The Glory Quiz: Persistent Oral Lesions, Nevus or Melanoma?, Altered Mental Status in Middle Age, An Itchy, Scaly Rash, Painful Blisters of the Hand
  • Scaly Plaque on the Nose
  • T-Wave Inversions: Sorting Through the Causes
  • Tuberculosis Diagnosis With Handheld Device
  • Physician, First Do No Harm—To Yourself
  • Making the Most of Antihypertensive Drug Combinations
  • Why Doctors Commit Suicide
  • Superficial Abrasion After a Fall From a Bicycle
  • Women Underrepresented in Antiretroviral Clinical Trials
  • Crohn’s Disease: New Scoring System Predicts Mild Disease
  • Iron-deficiency Anemia in IBD: These Patients Need Primary Care
  • Statins Plus Exercise: New Study Questions the Combination
  • Benign Congenital Nevus
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Nodular Basal Cell Carcinoma
  • Short on Physicians, Long on Adverse Effects
  • Wanted: Physician Feedback on Medical Cannabis
  • Why Doctors Commit Suicide
  • Crusted Scabies
  • Scaly Plaque on the Nose
  • Short on Physicians, Long on Adverse Effects
  • Furuncle Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
  • Resistant Hypertension: Four Pearls for Your Practice
  • Nodular Basal Cell Carcinoma
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Gout
Evidence on Gout
Guidelines on Gout
Patient Education on Gout
Clinical Trials on Gout
Practical Articles on Gout
Research and Reviews on Gout
All "Gout" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy